Cipher Pharmaceuticals Inc.
TSX:CPH.TODrug Manufacturers - Specialty & Generic
+$0.15 today
- Market cap
- $331.67M
- Beta
- 0.48
- P/E (TTM)
- 9.3
- EPS (TTM)
- $1.22
Volume 0.04M
Average 0.03M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Cipher Pharmaceuticals Inc.
TSX:CPH.TO
Intrinsic Alpha fair value
Locked
Current Price
$13.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +1.0% | -3.4% (5yr)1 analysts |
| Revenue | N/A | N/A | +35.4% | +4.1% (5yr)1 analysts |
| Net Income | N/A | N/A | +1.4% | -3.4% (5yr)1 analysts |
| EBIT | N/A | N/A | +11.8% | +8.5% (5yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +35.4% over three years. Forward estimates point to EBIT at +8.5% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Knight Therapeutics Inc. TSX:GUD.TO | $1.18B | $12.06 | Undervalued | 164.6 | +88.58% |
Fennec Pharmaceuticals Inc. TSX:FRX.TO | $580.71M | $16.56 | Not rated | -36.5 | +58.04% |
Aurora Cannabis Inc. TSX:ACB.TO | $463.50M | $7.05 | Not rated | -3.2 | +3.95% |
Canopy Growth Corporation TSX:WEED.TO | $364.19M | $0.81 | Not rated | -1.8 | -51.35% |
Spectral Medical Inc. TSX:EDT.TO | $293.55M | $1.00 | Not rated | -10.5 | -23.90% |
TerrAscend Corp. TSX:TSND.TO | $201.10M | $0.54 | Not rated | -2.5 | -1.89% |
OrganiGram Holdings Inc. TSX:OGI.TO | $166.39M | $1.18 | Not rated | -7.2 | -54.72% |
Continue the stock analysis
Jump to another research area for this company.